How the pandemic has changed our approach to stakeholder engagement

McKinsey & Company recently undertook a survey of senior executives in commercial roles within global pharma, to understand their thoughts on how the pandemic has influenced and changed the strategic and operational approach to ongoing engagement.

The report focuses on the acceleration of certain commercial-organizational trends, with building digital capabilities taking precedence. The priority was to recreate engagement virtually and without placing an additional burden on already stretched stakeholders.

There was an overwhelming view that companies would embrace agile ways of working, with raising digital capabilities, expanding field roles, increasing subject matter expert accessibility for customers, proactive marketing and new business development capabilities, seen as having high value.

In summary, the report highlights the opportunity the pandemic has presented to revisit investment in time and resources. It illustrates the importance of delivering relevant communications to HCPs, particularly given the additional pressures they are facing. Quality over quantity definitely wins.

To read the full report, visit https://www.mckinsey.com/industries/life-sciences/our-insights/a-new-operating-model-for-pharma-how-the-pandemic-has-influenced-priorities

Related news

Omnichannel metrics

Measuring omnichannel success

What does success look like? Is it simply proving return on investment – the thing all marketers talk about, and one of the hardest things to provide tangible evidence for?! Or are there other measures of success that can deliver the reassurance that the approach taken is the right one?

New technologies for HCP engagement

Is pharma investing in the right digital solutions?

Digital transformation has gathered pace in pharma and we have all been witnessing the acceleration. New technologies have been adopted to ensure HCP engagement is maintained but keeping up the understanding of innovative and emerging solutions and investing in the right technologies may prove challenging.

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.